term.subject="guideline"

Print version: Uselton, John P. ; Meeting accreditation standards, Centers for Medicaid & Medicare Services / Kurt A. Patton, MS, RPh -- The Joint Commission -- National Integrated Accreditation for Healthcare Organizations Surveys / Cynthia Williams, BS Pharm, FASHP -- Healthcare Facilities Accreditation Program Surveys -- Center for Improvement in Healthcare Quality -- Achieving Continuous Compliance / Amanda J. Hayes, PharmD, MHA -- Document Checklist -- Medication Management Standards Checklist -- National Patient Safety Goals Checklist / Natasha Nicol, PharmD, FASHP -- Infection Prevention and Control Checklist -- Environment of Care Checklist -- Human Resources Standards Checklist -- United States Pharmacopeia Compounding Standards -- Medication Management Tracers / Dima Awad., PharmD, MS -- Pharmacy and Therapeutics Activities / Dustin D. Spencer, PharmD, MBA, BCPS, BCCP -- Medication Safety Improvement / NatashaNicol, PharmD, FASHP -- Pain Management / Nisha Pherwani Singh, PharmD, BCOP -- Antimicrobial Stewardship / Katherine B. Shea, PharmD, BCIDP, AAHIVE -- Quality and Performance Measures / Iris Young, PharmD, CPHQ, Preceded by Assuring continuous compliance with Joint Commission standards : a pharmacy guide / John P. Uselton, Patricia C. Kienle, Lee B. Murdaugh. 8th ed. c2010

Additional physical form, Staffing -- Program activities for healthy development -- Health promotion and protection -- Nutrition and food service -- Facilities, supplies, equipment, and environmental health -- Play areas/playgrounds and transportation -- Infectious diseases -- Children with special health care needs and disabilities -- Administration -- Licensing and community action

Print version: American Psychiatric Association, author, issuing body ; American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder, Cover; Title Page; Contents; Acronyms/Abbreviations; Introduction; Overview of the Development Process; Rating the Strength of Research Evidence and Recommendations; Proper Use of Guidelines; Rationale; Guideline Statement Summary; Guideline Statements and Implementation; Assessment and Determination of Treatment Goals; Statement 1: Assessment of Substance Use; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 2: Use of Quantitative Behavioral Measures; Implementation, Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline StatementQuality Measurement Considerations; Statement 3: Use of Physiological Biomarkers; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 4: Assessment of Co-occurring Conditions; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 5: Determination of Initial Treatment Goals; Implementation, Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline StatementQuality Measurement Considerations; Statement 6: Discussion of Legal Obligations; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 7: Review of Risks to Self and Others; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 8: Evidence-Based Treatment Planning; Implementation, Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline StatementQuality Measurement Considerations; Selection of a Pharmacotherapy; Statement 9: Naltrexone or Acamprosate; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 10: Disulfiram; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 11: Topiramate or Gabapentin; Implementation, Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline StatementQuality Measurement Considerations; Recommendations Against Use of Specific Medications; Statement 12: Antidepressants; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 13: Benzodiazepines; Implementation; Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement; Quality Measurement Considerations; Statement 14: Pharmacotherapy in Pregnant or Breastfeeding Women

Print version: Field guide for air and ground transport of neonatal and pediatric patients, Before the transport -- Challenges of transport environment -- Special considerations -- Diagnostic tests -- Procedural skills -- Radiology pearls -- Neonatal content -- Pediatric content -- Approach to selected signs and symptoms

Print version: Marrelli, T.M. ; Hospice and palliative care handbook, Hospice Care: An Overview of Quality and Compassionate Care -- Documentation: An Important Driver for Care and Coverage -- Planning, Managing, and Coordinating Care -- Hospice Diagnoses and Guidelines for Care -- Hospice Conditions of Participation: Subpart B-Eligibility, Election, and Duration of Benefits -- Hospice Conditions of Participation: Subpart F-Covered Services -- State Hospice and Palliative Care Organizations

Print version: Guidelines for perinatal care, Organization of perinatal health care -- Inpatient perinatal care services -- Quality improvement and patient safety -- Maternal and neonatal interhospital transfer -- Preconception care -- Antepartum care -- Intrapartum care of the mother -- Postpartum care of the mother -- Medical and obstetric complications -- Care of the newborn -- Neonatal complications and management of high-risk infants -- Perinatal infections -- Infection control, Revised edition of: Guidelines for perinatal care / American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. 7th ed. ©2012

Print version: Coughlin, Mary ; Trauma-informed care in the NICU, Trauma and the NICU experience -- Core measures for age-appropriate care -- Trauma-informed, age-appropriate care in the NICU -- Summary : the need for standardization of trauma-informed age-appropriate care in the NICU -- Guidelines for the healing environment -- Guidelines for pain and stress prevention, assessment, management, and family -- Guidelines for protected sleep -- Guidelines for activities of daily living -- Guidelines for family collaborative care -- Meeting the needs of the neonatal clinician -- Self-care guidelines for the neonatal clinician, "Follow-up to Transformative nursing in the NICU: trauma-informed, age-appropriate care. This book is the direct result of my experience working with the amazing and dedicated neonatal intensive care unit (NICU) team at Children's Healthcare of Atlanta, Engleston campus"--Preface

Print version: Managing infectious diseases in child care and schools, Includes index

Print version: American Academy of Ambulatory Care Nursing ; Scope & standards of practice for professional ambulatory care nursing, Pages:1 to 10; Pages:11 to 20; Pages:21 to 30; Pages:31 to 40; Pages:41 to 48, Preceded by Scope and standards of practice for professional ambulatory care nursing / American Academy of Ambulatory Care Nursing. 8th edition. 2010

Print version: Bright futures, What Is Bright Futures? An introduction to the fourth edition of Bright futures: guidelines for health supervision of infants, children, and adolescents -- Bright futures health promotion themes -- An introduction to the bright futures health promotion themes -- Promoting lifelong health for families and communities -- Promoting family support -- Promoting health for children and youth with special health care needs -- Promoting healthy development -- Promoting mental health -- Promoting healthy weight -- Promoting healthy nutrition -- Promoting physical activity -- Promoting oral health -- Promoting healthy sexual development and sexuality -- Promoting the healthy and safe use of social media -- Promoting safety and injury prevention -- Bright futures health supervision visits -- An introduction to the bright futures health supervision visits -- Evidence and rationale -- Infancy visits (prenatal through 11 months) -- Early childhood visits (1 through 4 years) -- Middle childhood visits (5 through 10 years) -- Adolescence visits (11 through 21 years) -- Appendices. World Health Organization growth charts -- Centers for Disease Control and Prevention growth charts -- Appendix C: Bright Futures/American Academy of Pediatrics recommendations for preventive pediatric health care (periodicity schedule), Bright futures : guidelines for health supervision of infants, children, and adolescents / editors, Joseph F. Hagan, Judith S. Shaw, Paula M. Duncan. Third edition. ©2008